Skip to content
OpenCapital
Get started

Envista Holdings Corporation NVST Cash & Equivalents

Cash & Equivalents at other companies

Henry Schein logo
Henry ScheinHSIC
$138M+8.7%
Align Technology logo
Align TechnologyALGN
$1.06B+21.4%
Solventum logo
SolventumSOLV
$561M+5.1%
Organon logo
OrganonOGN
$1.12B+104%
Globus Medical logo
Globus MedicalGMED
$560.95M+21.6%
Novanta logo
NovantaNOVT
$388.8M+267%

Other financials

Income statement

See full
Revenue$705.5M+14.4%
Gross profit$390.1M+16.1%
Operating income$62.5M+60.3%
Net income$38.7M+115%
EPS (diluted)$0.23+130%

Balance sheet

See full
Total debt$1.6B+1.8%
Total equity$3.1B+1.4%
Total assets$5.6B+2.0%

Cash flow

See full
Operating cash flow-$3.3M-1,200%
CapEx$12.5M+112%
Free cash flow-$15.8M-182%

Valuation

See full
Market cap$4.22B+39.9%
Enterprise value$4.72B+35.0%
P/E62.3×—
P/S1.5×+0.3×

Profitability

See full
Gross margin54.9%+0.9pp
Operating margin8.5%+4.6pp
Net margin2.4%+1.2pp
FCF margin7.8%-2.9pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.5×0.0×
Current ratio2.4×+0.3×

Where this comes from

Reported directly by Envista Holdings Corporation in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Envista Holdings Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envista Holdings Corporation's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envista Holdings Corporation's cash & equivalents?
Envista Holdings Corporation (NVST) reported cash & equivalents of $1.08B in Q1 2026.
How has Envista Holdings Corporation's cash & equivalents changed year-over-year?
Envista Holdings Corporation's cash & equivalents increased by 0.5% year-over-year, from $1.08B to $1.08B.
What is the long-term trend for Envista Holdings Corporation's cash & equivalents?
Over 5 years (2020 to 2025), Envista Holdings Corporation's cash & equivalents has grown at a 6.4% compound annual growth rate (CAGR), from $888.9M to $1.21B.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.